English | Español
Kerry Goff | Jan 11, 2016

Aalto Bio Reagents announces first HBV human plasma for diagnostic test kits, QC panels
Jamie Barrand | Jan 9, 2016

CMS director outlines plans to improve organization's health care delivery system
Jamie Barrand | Jan 8, 2016

FDA approves record number of orphan drugs in 2015
Jamie Barrand | Jan 8, 2016

Children born as result of infertility treatments no more likely to experience developmental delays
Jamie Barrand | Jan 8, 2016

FDA grants priority review to therapy for HCV, cirrhosis

Jamie Barrand | Jan 8, 2016

International pharmaceutical study uncovers new drug combination as possible HIV therapy
Jamie Barrand | Jan 8, 2016

FDA indicates Omnigraft wound dressing for treatment of diabetic foot ulcers
Jamie Barrand | Jan 8, 2016

FDA emphasizes importance of hearing aid use, plans public workshop

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’